More people with ovarian cancer are surviving longer after diagnosis in Somerset then almost anywhere else in the country, a ...
New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.
Ovarian cancer affects anyone with ovaries, most commonly women who are older than 50, the NHS explains - here are the ...
Researchers at the University of Pittsburgh have found special high-risk cells in the fallopian tubes that may trigger ...
AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx) in women with folate ...
Pitt research uncovers new insights into ovarian cancer origins, shedding light on potential early detection and treatment ...
Verywell Health on MSN1d
The 3 Types of Ovarian Cancer and How They Are DifferentThere are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...
Researchers at the University of Pittsburgh have identified a novel trigger for a deadly form of ovarian cancer: a subset of ...
The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα expression of 25% or greater -SOUTH SAN FRANCISCO, Calif., March 15, ...
AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE� (mirvetuximab soravtansine-gynx) in women with folate ...
A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new research.
Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback